Supply Chain | March 30, 2023
Granules India inaugurates packaging facility in Virginia
The facility is over 79,000 square feet and is equipped with packaging lines
The facility is over 79,000 square feet and is equipped with packaging lines
Supply increase to help meet growing global demand
Virginia will be responsible for meeting client needs for both media and commercial analytics.
YESAFILI, a vascular endothelial growth factor (VEGF) inhibitor, is used to treat several different types of ophthalmology conditions
There are 38.4 million people with diabetes in the United States
Approval is based on positive data from the Phase 3 ECHELON-3 trial
_256_384.jpg)
Tyvek with Renewable Attribution is designed to help reduce the carbon footprint
Granules Pharmaceuticals gets 5 observations from USFDA on completion of GMP inspection
The sBLA is supported by a usability study which confirmed that individuals over 18 years of age could self-administer
The inspection was conducted at Granules Pharmaceuticals Inc. (GPI) from July 31, 2023 to August 03, 2023
Subscribe To Our Newsletter & Stay Updated
